Rahimi Farahani Marjan, Sharifi Farshad, Payab Moloud, Shadman Zhaleh, Fakhrzadeh Hossein, Moodi Mitra, Khorashadizadeh Masoumeh, Ebrahimpur Mahbube, Taheri Maryam, Ebrahimi Pouya, Larijani Bagher
Non-communicable Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2024 Oct 21;23(2):2343-2353. doi: 10.1007/s40200-024-01501-8. eCollection 2024 Dec.
Abdominal obesity and low muscle strength, known separately as risk factors for mortality, might have a synergistic effect when they co-occur. Dynapenic abdominal obesity (DAO) is a condition defined by the presence of both. However, DAO's independent and combined impact on mortality remains under investigation.
The objective of the present study was to evaluate the association of dynapenia, abdominal obesity, and dynapenic abdominal obesity with all-cause mortality among community-dwelling older adults.
This is a longitudinal study with a 5-year follow-up conducted involving 1,354 community-dwelling older adults (≥ 65 years) of the Birjand Longitudinal Aging Study (BLAS). Abdominal obesity and dynapenia were respectively defined based on waist circumference (> 102 cm for men and > 88 cm for women) and grip strength (< 26 kg for men and < 16 kg for women). The sample was divided into four groups: non-dynapenic/non-abdominal obesity (ND/NAO), dynapenic/non-abdominal obesity (D/NAO), non-dynapenic/abdominal obesity (ND/AO), and dynapenic/abdominal obesity (D/AO). The outcome was all-cause mortality registered through four methods: 1- telephone interview with the family of the participants during September 2018 and February 2024, 2- hospital information systems, 3- death registry of the deputy of the Health of Birjand University of Medical Sciences 4- in a subject who died at home or out of hospital death registry was verified by a verbal autopsy performed by a clinician. Univariate and multiple Logistic regression models were used to estimate the risk of all-cause mortality as a function of dynapenia and abdominal obesity in competing events controlled by age, sex, multi-morbidity, and frailty.
The mean age of the study participants was 69.77 ± 7.55 years, and about 703 (51.71%) were female. There was a statistical difference between the alive and the deceased groups in terms of sex, age, multimorbidity, and frailty. Mortality was statistically higher among dynapenic participants ( < 0.001). Unadjusted logistic regression analysis explored the relationship between D/NAO and mortality (OR = 2.18; CI 95% 1.25-3.78). In the adjusted models, no significant relationships were observed. Age and frailty had significant associations with mortality.
While our study found an association between dynapenia without abdominal obesity and increased mortality risk, factors like age and frailty might play a stronger role. These require further investigation to understand the independent effect of dynapenia on mortality fully.
The online version contains supplementary material available at 10.1007/s40200-024-01501-8.
腹部肥胖和肌肉力量低下,分别被认为是死亡的危险因素,当两者同时出现时可能会产生协同作用。肌少性腹部肥胖(DAO)是一种由两者同时存在所定义的状况。然而,DAO对死亡率的独立及综合影响仍在研究中。
本研究的目的是评估肌少症、腹部肥胖和肌少性腹部肥胖与社区居住的老年人全因死亡率之间的关联。
这是一项为期5年随访的纵向研究,涉及比尔詹德纵向衰老研究(BLAS)中的1354名社区居住的老年人(≥65岁)。腹部肥胖和肌少症分别根据腰围(男性>102厘米,女性>88厘米)和握力(男性<26千克,女性<16千克)来定义。样本被分为四组:非肌少症/非腹部肥胖(ND/NAO)、肌少症/非腹部肥胖(D/NAO)、非肌少症/腹部肥胖(ND/AO)和肌少症/腹部肥胖(D/AO)。结局是通过四种方法记录的全因死亡率:1-2018年9月至2024年2月期间与参与者家属进行电话访谈;2-医院信息系统;3-比尔詹德医科大学健康部副部长的死亡登记处;4-对于在家中死亡或未在医院死亡登记处登记的受试者,由临床医生进行的口头尸检来核实。使用单变量和多变量逻辑回归模型,在控制年龄、性别、多种疾病和虚弱状态的竞争事件中,估计肌少症和腹部肥胖对全因死亡率的风险。
研究参与者的平均年龄为69.77±7.55岁,约703人(51.71%)为女性。在存活组和死亡组之间,在性别、年龄、多种疾病和虚弱状态方面存在统计学差异。肌少症参与者的死亡率在统计学上更高(<0.001)。未调整的逻辑回归分析探讨了D/NAO与死亡率之间的关系(OR = 2.18;95%CI 1.25 - 3.78)。在调整模型中,未观察到显著关系。年龄和虚弱状态与死亡率有显著关联。
虽然我们的研究发现无腹部肥胖的肌少症与死亡率增加之间存在关联,但年龄和虚弱等因素可能起更强的作用。这些需要进一步研究以充分了解肌少症对死亡率的独立影响。
在线版本包含可在10.1007/s40200-024-01501-8获取的补充材料。